Clorox Company (The) (CLX) Stock Analysis — Fair Value, Risk & Moat Rating
NYQ · Consumer Defensive · Household & Personal Products
Is Clorox Company (The) a safe investment right now?
As of Aug 13, 2026, our estimated fair value (intrinsic value) for Clorox Company (The) (CLX) stock is $97.43, versus a market price of $105.70 — Fairly Valued. Predicted EPS $5.21 x 18.7 Fair PE.
Clorox Company (The)'s Altman Z-Score of 2.19 places it in the gray zone. Our fair value estimate is $97.43 (Fairly Valued). Moat rating: 3.7/5 stars.
Could Clorox Company (The) go bankrupt? Altman Z-Score analysis
Z-Score of 2.19 places the company in the gray zone (1.8-3.0), warranting closer scrutiny.
- Below 1.8 — Distress Zone (high bankruptcy risk)
- 1.8 to 3.0 — Gray Zone (elevated uncertainty)
- Above 3.0 — Safe Zone (financially healthy)
What drives CLX's Z-Score?
| Component | Formula | Value | Weight | Contribution |
|---|---|---|---|---|
| A · Working Capital / Total Assets | WC / TA | -0.1218 | 1.2 | -0.15 |
| B · Retained Earnings / Total Assets | RE / TA | 0.0495 | 1.4 | 0.07 |
| C · EBIT / Total Assets | EBIT / TA | 0.1182 | 3.3 | 0.39 |
| D · Market Cap / Total Liabilities | MCap / TL | 1.6948 | 0.6 | 1.02 |
| E · Revenue / Total Assets | Rev / TA | 0.8622 | 1.0 | 0.86 |
How has CLX's financial health changed over time?
| Year | Z-Score | Zone |
|---|---|---|
| 2023 | 2.92 | Gray |
| 2024 | 3.04 | Safe |
| 2025 | 3.52 | Safe |
| 2026 | 2.19 | Gray |
Source: Calculated from CLX's latest 10-K filing on SEC EDGAR.
Clorox Company (The) Fair Value & Intrinsic Value — What Is It Actually Worth?
How we calculated this
| Input | Value | Source |
|---|---|---|
| Predicted EPS (α) | $5.21 | Proprietary blend of reported actuals + analyst consensus, weighted by α |
| Last Year EPS | $4.81 | Annual report (SEC EDGAR) |
| Analyst Consensus EPS (This Year) | $5.81 | 17 analysts consensus |
| Trailing P/E | 22.0x | Current market pricing |
| Fair P/E (β discount) | 18.7x | Trailing PE adjusted by value discount factor β, hard-capped |
| Earnings Trend (γ) | Growing | Directional signal: predicted vs trailing EPS |
Wall Street Reference: Analyst consensus target price is $101.71 (17 analysts). This is shown for reference only and is not used in our valuation model.
Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.
Does Clorox Company (The) have a durable competitive advantage?
Moat rating: 3.7/5.
What makes up CLX's moat score?
ROIC Stability
ROIC variability over the past decade. Score: 4/5.
Gross Margin Trend
Gross margin trajectory over the past decade. Score: 4/5.
Switching Costs
Estimated customer lock-in based on margin level. Score: 3/5.
How stable is CLX's return on invested capital?
| Year | ROIC | Trend |
|---|---|---|
| 2023 | 11.9% | — |
| 2024 | 17.3% | Rising |
| 2025 | 41.5% | Rising |
| 2026 | 17.9% | Declining |
Source: ROIC calculated from SEC EDGAR filings.
Is Clorox Company (The)'s dividend safe?
Can Clorox Company (The) afford its dividend?
Payout ratio is 103.1%. FCF covers the dividend 1.6x. 45 consecutive years of payments.
US dividend withholding tax of 30% applies to non-US tax residents. This rate may be reduced under a tax treaty between the US and your country of residence. The adjusted yield shown assumes the default 30% rate. For informational purposes only — consult a qualified tax advisor.
Clorox Company (The)'s key financial metrics
| Metric | Latest | 1Y Ago | 3Y Ago | Trend |
|---|---|---|---|---|
| Revenue | $6.7B | $7.1B | $7.4B | Declining |
| Net Income | $0.6B | $0.8B | $0.1B | Rising |
| Free Cash Flow | $0.4B | $0.8B | $0.9B | Declining |
| Gross Margin | 42.3% | 45.2% | 39.4% | Rising |
Recent events that affect our CLX analysis
CLX earnings report scheduled
Upcoming report. Consensus EPS estimate: $1.11. Revenue estimate: $1.88B. Our current Fair Value: $97.43 — a significant beat or miss could shift this estimate.
CLX analyst consensus: 5% bullish (1 of 19 analysts)
0 Strong Buy, 1 Buy, 14 Hold, 2 Sell, 2 Strong Sell. Consensus target: $101.71 (3.8% downside). Compare with our independent Fair Value: $97.43.
CLX paid $1.2500/share dividend
Dividend Safety Grade: B. Payout ratio: 103.1%.
CLX filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
CLX beat EPS estimates by 0.9%
Reported EPS: $1.66 vs estimate $1.65. Earnings strength supports our Fair Value of $97.43 (7.8% below current price).
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX beat EPS estimates by 6.2%
Reported EPS: $1.64 vs estimate $1.54. Earnings strength supports our Fair Value of $97.43 (7.8% below current price).
CLX filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX paid $1.2400/share dividend
Dividend Safety Grade: B. Payout ratio: 103.1%.
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX missed EPS estimates by 3.0%
Reported EPS: $1.39 vs estimate $1.43. Our Fair Value of $97.43 may face downward pressure if the trend continues.
CLX filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX paid $1.2400/share dividend
Dividend Safety Grade: B. Payout ratio: 103.1%.
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX beat EPS estimates by 9.2%
Reported EPS: $0.85 vs estimate $0.78. Earnings strength supports our Fair Value of $97.43 (7.8% below current price).
CLX filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX paid $1.2400/share dividend
Dividend Safety Grade: B. Payout ratio: 103.1%.
CLX paid $1.2400/share dividend
Dividend Safety Grade: B. Payout ratio: 103.1%.
CLX filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
CLX beat EPS estimates by 29.8%
Reported EPS: $2.87 vs estimate $2.21. Earnings strength supports our Fair Value of $97.43 (7.8% below current price).
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX missed EPS estimates by 6.9%
Reported EPS: $1.45 vs estimate $1.56. Our Fair Value of $97.43 may face downward pressure if the trend continues.
CLX filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX paid $1.2200/share dividend
Dividend Safety Grade: B. Payout ratio: 103.1%.
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX beat EPS estimates by 10.7%
Reported EPS: $1.55 vs estimate $1.40. Earnings strength supports our Fair Value of $97.43 (7.8% below current price).
CLX filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
CLX paid $1.2200/share dividend
Dividend Safety Grade: B. Payout ratio: 103.1%.
CLX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
Common questions about Clorox Company (The)
What is Clorox Company (The) stock price today?
Clorox Company (The) (CLX) stock price is $105.70 as of the latest market close, traded on the NYSE exchange.
What does Clorox Company (The) do?
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand in the United States.
What is Clorox Company (The) market cap?
Clorox Company (The) has a market capitalization of $12.78B, classifying it as a large-cap stock in the Consumer Defensive sector.
What sector and industry is CLX in?
Clorox Company (The) operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. It trades on the NYSE under the ticker symbol CLX.
Is CLX stock overvalued or undervalued?
Based on our valuation model, Clorox Company (The) trades 8.5% above our fair value estimate — potentially overvalued.
- FairValueLabs Fair Value: $97.43
- Current Price: $105.70
- Valuation Zone: Fairly Valued
What is CLX stock forecast and analyst target price?
Based on 17 Wall Street analysts, the consensus price target for Clorox Company (The) is $101.71, implying downside of 3.8% from the current price.
- Analyst High Target: $155.00
- Analyst Low Target: $77.00
Note: Analyst targets are shown for reference and are not used in our valuation model.
Is Clorox Company (The) revenue and earnings growing?
Here are the analyst consensus growth estimates for Clorox Company (The):
- Revenue growth (current year est.): 13.6%
- EPS growth (current year est.): 5.0%
- Revenue growth (next year est.): 2.1%
- EPS growth (next year est.): 9.5%
What are Clorox Company (The)'s key financial metrics?
| Metric | Latest | Trend |
|---|---|---|
| Revenue | $6.7B | Declining |
| Net Income | $0.6B | Rising |
| Free Cash Flow | $0.4B | Declining |
| Gross Margin | 42.3% | Rising |
What is CLX's P/E ratio?
The price-to-earnings ratio measures how much investors pay per dollar of earnings:
- Trailing P/E (last 12 months): 22.0x
- Forward P/E (next 12 months est.): 16.6x
- FairValueLabs Fair P/E: 18.7x
How volatile is CLX stock?
Clorox Company (The) has a beta of 0.54, meaning it is less volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.
How much cash and debt does Clorox Company (The) have?
Clorox Company (The)'s balance sheet shows:
- Total Cash: $143.0M
- Total Debt: $5.60B
- Net Cash Position: $-5.46B
A positive net cash position means the company holds more cash than debt, reducing financial risk.
What is Clorox Company (The)'s free cash flow?
Clorox Company (The) generated $110.4M in trailing twelve-month free cash flow (from $612.0M in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.
Does Clorox Company (The) pay a dividend, and is it safe?
Yes, Clorox Company (The) pays a regular dividend. Here are the key metrics:
- Dividend Yield: 4.7%
- Payout Ratio: 103.1%
- Consecutive Years Paid: 45
- 5-Year Dividend Growth: -3.9%
- FairValueLabs Safety Grade: B
Is Clorox Company (The) at risk of going bankrupt?
Clorox Company (The)'s Altman Z-Score is 2.19, placing it in the gray zone (1.8–3.0) — some financial uncertainty. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.
Does Clorox Company (The) have a durable competitive advantage?
Clorox Company (The) scores 3.7/5 stars (Solid moat · eroding) in our moat analysis:
- ROIC Stability: 4/5
- Gross Margin Trend: 4/5
- Switching Costs: 3/5
A score above 3.5 suggests meaningful pricing power and a defensible market position.
What is CLX's return on equity (ROE)?
Clorox Company (The)'s return on equity is 163.8%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.
How do I buy CLX stock?
CLX shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:
- Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
- Search for ticker symbol CLX
- Place a market or limit order for your desired number of shares
This is not investment advice. Always do your own research before buying any stock.
Is CLX a value stock or speculative?
FairValueLabs classifies Clorox Company (The) as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.
Who is the CEO of Clorox Company (The)?
The current CEO of Clorox Company (The) is Ms. Linda J. Rendle.
What is CLX's earnings per share (EPS)?
Earnings per share measures the company's profit allocated to each outstanding share:
- Trailing EPS (last 12 months): $4.80
- Forward EPS (next 12 months est.): $6.36
- Analyst consensus EPS (this year): $5.81
- Analyst consensus EPS (next year): $6.36
Other Consumer Defensive companies analyzed by FairValueLabs
FairValueLabs Disclaimer
All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.
This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.
Last updated: Aug 13, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.
CLX analysis methodology: How we calculate fair value, Z-Scores, and moat ratings